Lockerman Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $384K | Buy |
863
+15
| +2% | +$6.68K | 0.52% | 60 |
|
|
2025
Q1 | $411K | Sell |
848
-1
| -0.1% | -$485 | 0.62% | 48 |
|
|
2024
Q4 | $342K | Hold |
849
| – | – | 0.58% | 51 |
|
|
2024
Q3 | $395K | Buy |
849
+17
| +2% | +$7.91K | 0.67% | 48 |
|
|
2024
Q2 | $390K | Buy |
832
+298
| +56% | +$140K | 0.71% | 41 |
|
|
2024
Q1 | $223K | Buy |
+534
| New | +$223K | 0.43% | 91 |
|